Literature DB >> 11434427

Molecular virology of hepatitis C virus.

N Kato1.   

Abstract

Hepatitis C virus (HCV), discovered in 1989, is the major causative agent of parenteral non-A, non-B hepatitis worldwide. Following the development of a method of diagnosing HCV infection, it became apparent that HCV frequently causes chronic hepatitis. Persistent infection with HCV is implicated in liver cirrhosis and hepatocellular carcinoma. Current worldwide estimations suggest that more than 170 million people have been infected with HCV, an enveloped positive single-stranded RNA (9.6-kilobases) virus belonging to the Flaviviridae. The HCV genome shows remarkable sequence variation, especially in the hypervariable region 1 of the E2 protein-encoding region, and globally, HCV appears to be distributed with more than 30 genotypes. Complicated "quasispecies" and frequent mutations of viral genomes have also emerged. The HCV genome encodes a large polyprotein precursor of about 3,000 amino acid residues, and this precursor protein is cleaved by the host and viral proteinases to generate at least 10 proteins in the following order: NH2-core-envelope (E1)-E2-p7-nonstructural protein 2 (NS2)-NS3-NS4A-NS4B-NS5A-NS5B-COOH. These viral proteins not only function in viral replication but also affect a variety of cellular functions. Although several explanations have been proposed, the mechanisms of HCV infection and replication in targeted cells, the mechanism of persistent viral infection, and the pathogenesis of hepatic diseases (hepatitis or hepatocellular carcinoma) are all poorly understood. A major reason why these mechanisms remain unclear is the lack of a good experimental HCV replication system. Although several classical trials using cultured cells have been reported, several new, more promising experimental strategies (generations of infectious cDNA clone, replicon, animal models, etc.) are currently being designed and tested, in order to resolve these problems. In addition, new therapies for chronic hepatitis have also been developed. The enormous body of information collected thus far in the field of HCV research is summarized below, and an overview of the current status of HCV molecular virology of HCV is provided.

Entities:  

Mesh:

Year:  2001        PMID: 11434427     DOI: 10.18926/AMO/32025

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  37 in total

1.  Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein.

Authors:  Qiong-Qiong He; Rui-Xue Cheng; Yi Sun; De-Yun Feng; Zhu-Chu Chen; Hui Zheng
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  Dimerization of the hepatitis C virus nonstructural protein 4B depends on the integrity of an aminoterminal basic leucine zipper.

Authors:  Martin-Walter Welker; Christoph Welsch; Aline Meyer; Iris Antes; Mario Albrecht; Nicole Forestier; Bernd Kronenberger; Thomas Lengauer; Albrecht Piiper; Stefan Zeuzem; Christoph Sarrazin
Journal:  Protein Sci       Date:  2010-07       Impact factor: 6.725

Review 3.  Medicinal plants against hepatitis C virus.

Authors:  Usman A Ashfaq; Sobia Idrees
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  Molecular characterization and clinical epidemiology of HCV in District Dir (Lower), Pakistan.

Authors:  Sami Ullah; Muhammad Akram Khan; Shafiq Ur Rahman; Imran Khan; Fazal Akbar; Anshu Babbar
Journal:  Virusdisease       Date:  2018-05-17

5.  A case of fulminant liver failure associated with hepatitis C virus.

Authors:  Hiromitsu Kanzaki; Akinobu Takaki; Takahito Yagi; Fusao Ikeda; Tetsuya Yasunaka; Kazuko Koike; Yasuhiro Miyake; Yoshiaki Iwasaki; Kazuhiro Nouso; Hiroshi Sadamori; Susumu Shinoura; Yuzo Umeda; Ryuichi Yoshida; Masashi Utusmi; Toshiyoshi Fujiwara; Kazuhide Yamamoto
Journal:  Clin J Gastroenterol       Date:  2014-01-18

6.  Screening of genes of proteins interacting with p7 protein of hepatitis C virus from human liver cDNA library by yeast two-hybrid system.

Authors:  Yan-Ping Huang; Shu-Lin Zhang; Jun Cheng; Lin Wang; Jiang Guo; Yan Liu; Yuan Yang; Li-Ying Zhang; Gui-Qin Bai; Xue-Song Gao; Dong Ji; Shu-Mei Lin; Yan-Wei Zhong; Qing Shao
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

Review 7.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Hepatitis C virus infection in phenotypically distinct Huh7 cell lines.

Authors:  Bruno Sainz; Naina Barretto; Susan L Uprichard
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

Review 9.  New therapeutic approaches to hepatitis C virus.

Authors:  Naoya Sakamoto; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-05-21       Impact factor: 7.527

10.  High prevalence of hepatitis C virus genotype 1b infection in a small town of Argentina. Phylogenetic and Bayesian coalescent analysis.

Authors:  Marcelo D Golemba; Federico A Di Lello; Fernando Bessone; Fabian Fay; Silvina Benetti; Leandro R Jones; Rodolfo H Campos
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.